3D IN VITRO MODELS FOR BETTER PREDICTION OF CLINICAL OUTCOMES
WHO WE ARE
A passionate, rigorous and dedicated team of scientists who deliver the highest quality services and products. Your reliable and knowledgeable partner.
WHAT WE DO
Learning from structures in the body, we recreate functional 3D in vitro models through innovation and science. Our models incorporate the “best biology” and are predictive of new drugs’ in vivo safety and efficacy.
HOW WE DO IT
Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology and organoid technology, we build functional pre-clinical in vitro models of kidney, retina, liver and lung. We engineer them from patient samples and a range of pre-clinical species.
WHY WE DO IT
Our purpose is to bridge the gap between scientific discovery and patients. We make a difference by providing better predictions of clinical outcomes.
WHO WE ARE
WHAT WE DO
HOW WE DO IT
WHY WE DO IT
services
RENAL DRUG SAFETY
aProximateTM is our state of the art in vitro proximal tubule cell model for renal safety and efficacy studies.
VIEW OUR MODELRENAL TRANSPORT AND DRUG-DRUG INTERACTION
aProximateTM is our state of the art in vitro proximal tubule cell model for renal transport investigations.
VIEW OUR MODELRENAL TRANSPORT AND DRUG-DRUG INTERACTION
aProximateTM is our state of the art in vitro proximal tubule cell model for renal transport investigations.
VIEW OUR MODELRETINA MODEL
An in vitro, iPSC-derived retinal organoid and companion retinal pigment epithelium for better prediction of in vivo outcomes.
VIEW OUR MODELNEW DEVELOPMENTS
LUNG EPITHELIA MODEL
In development, a 3D iPSC-derived model to investigate airway physiology, viral infection, drug safety, and environmental impacts on lung airway epithelia.
LIVER SINUSOID MODEL
We are developing an iPSC-derived model of liver sinusoid for safety and efficacy studies and disease modelling.
